Search
- Mar 19
BMO's Evan Seigerman takes a deep dive into the obesity space ahead of an investor summit
Evan Seigerman breaks down which companies and technologies are at the forefront of the the GLP space.
- Nov 16, 2023
BMO's Evan Seigerman joins Analyst Thursdays from London
Evan Seigerman discusses news from #AHA23, what's going on with Structure, Verve's polarizing result, Neurocrine, Vertex, Pfizer and more.
- Aug 31, 2023
BMO Capital Markets’ Evan Seigerman joins BiotechTV for Analyst Thursdays
Evan Seigerman gives his take on biotech and the CMS list, Lilly, Amgen, Skyscraper-01, Structure Therapeutics, Disc Medicine and Replimune.